Share on StockTwits

Neuralstem (NYSE:CUR) Insider Karl Johe sold 6,000 shares of Neuralstem stock in a transaction dated Monday, June 2nd. The shares were sold at an average price of $4.25, for a total transaction of $25,500.00. Following the completion of the transaction, the insider now directly owns 496,247 shares of the company’s stock, valued at approximately $2,109,050. The sale was disclosed in a filing with the SEC, which is available at this link.

Separately, analysts at Aegis raised their price target on shares of Neuralstem to $6.00 in a research note on Tuesday, May 27th.

Neuralstem (NYSE:CUR) traded up 0.93% on Monday, hitting $4.34. 976,224 shares of the company’s stock traded hands. Neuralstem has a 52-week low of $1.30 and a 52-week high of $4.80. The stock’s 50-day moving average is $3.72 and its 200-day moving average is $3.37. The company’s market cap is $376.5 million.

Neuralstem (NYSE:CUR) last announced its earnings results on Monday, May 12th. The company reported ($0.07) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.06) by $0.01. The company had revenue of $0.00 million for the quarter, compared to the consensus estimate of $0.35 million. On average, analysts predict that Neuralstem will post $-0.25 earnings per share for the current fiscal year.

Neuralstem, Inc is focused on developing and commercializing of treatments for central nervous system disease based on transplanting human neural stem cells and small molecule drugs.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.